|
|
Blood, 1 May 2005, Vol. 105, No. 9, pp. 3588-3595.
Prepublished online as a Blood First Edition Paper on December 16, 2004; DOI 10.1182/blood-2004-08-3251.
Previous Article | Next Article 
Submitted August 23, 2004
Accepted December 7, 2004
Reversal of long-term sepsis-induced immunosuppression by dendritic cell
Claudia F Benjamim, Steven K Lundy, Nicholas W Lukacs, Cory M Hogaboam, and Steven L Kunkel*
Department of Pathology, University of Michigan, Medical School, Ann Arbor, Michigan, USA
* Corresponding author; email: slkunkel{at}umich.edu.
Severe sepsis leads to long-term systemic and local immunosuppression, which is the cause of a number of complications, including pulmonary infection. A therapeutic strategy that reverses this immunosuppression is required, given the ongoing high mortality rate of patients that have survived a severe sepsis. The present study demonstrates that experimental severe sepsis renders the lung susceptible to a normally innocuous A. fumigatus fungus challenge, due to a dominant lung type-2 cytokine profile. Dendritic cells (DCs) obtained from lung of mice subjected to cecal ligation and puncture (CLP) model were skewed towards type 2 cytokine profile, which occurred with exaggerated expression of Toll-like receptor 2 (TLR2). The intrapulmonary transfer of bone-marrow derived DCs (BMDCs) in post-septic mice prevented fatal Aspergillus infection. This therapy reduced the overall inflammatory response, fungal growth in the lung and promote the balance of pro-inflamatory and supressive-cytokines in the lung. Thus, intrapulmonary DC supplementation appears to restore the pulmonary host response in the post-septic lung in our animal model. This data strongly suggests lung DCs are profoundly affected as a consequence of the systemic impact of severe sepsis and the identification of mechanisms that restore their function may serve as a key strategy to reverse sepsis-induced immunosuppression.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Pene, B. Zuber, E. Courtine, C. Rousseau, F. Ouaaz, J. Toubiana, A. Tazi, J.-P. Mira, and J.-D. Chiche
Dendritic Cells Modulate Lung Response to Pseudomonas aeruginosa in a Murine Model of Sepsis-Induced Immune Dysfunction
J. Immunol.,
December 15, 2008;
181(12):
8513 - 8520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Plitas, B. M. Burt, H. M. Nguyen, Z. M. Bamboat, and R. P. DeMatteo
Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis
J. Exp. Med.,
June 9, 2008;
205(6):
1277 - 1283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wen, M. A. Schaller, Y. Dou, C. M. Hogaboam, and S. L. Kunkel
Dendritic cells at the interface of innate and acquired immunity: the role for epigenetic changes
J. Leukoc. Biol.,
March 1, 2008;
83(3):
439 - 446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wen, Y. Dou, C. M. Hogaboam, and S. L. Kunkel
Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response
Blood,
February 15, 2008;
111(4):
1797 - 1804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wen, C. M. Hogaboam, J. Gauldie, and S. L. Kunkel
Severe Sepsis Exacerbates Cell-Mediated Immunity in the Lung Due to an Altered Dendritic Cell Cytokine Profile
Am. J. Pathol.,
June 1, 2006;
168(6):
1940 - 1950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Flohe, H. Agrawal, D. Schmitz, M. Gertz, S. Flohe, and F. U. Schade
Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response
J. Leukoc. Biol.,
March 1, 2006;
79(3):
473 - 481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Knapp, C. W. Wieland, S. Florquin, R. Pantophlet, L. Dijkshoorn, N. Tshimbalanga, S. Akira, and T. van der Poll
Differential Roles of CD14 and Toll-like Receptors 4and 2 in Murine Acinetobacter Pneumonia
Am. J. Respir. Crit. Care Med.,
January 1, 2006;
173(1):
122 - 129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Carpenter and C. M. Hogaboam
Immunosuppressive Effects of CCL17 on Pulmonary Antifungal Responses during Pulmonary Invasive Aspergillosis
Infect. Immun.,
November 1, 2005;
73(11):
7198 - 7207.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|